Searched for
MYLAN PHARMACEUTICAL
Solara Active Pharma to conduct internal probe on Nizatidine API amid Mylan recall"We understand from Mylan NV's press release dated January 8, 2020, that Mylan Pharmaceuticals has initiated a voluntary recall of three lo...09 Jan, 2020, 11.23 AM IST- Biocon, Mylan launch insulin biosimilar in AustraliaThe biotechnology major and pharmaceutical company Mylan N V announced the launch of their insulin biosimilar Semglee.03 Oct, 2019, 03.18 PM IST
- Mylan launches generic Hepatitis C drug in IndiaDrug firm Mylan NV has launched generic Harvoni tablets, used to treat Hepatitis C, under the brand name 'MyHep LVIR' in India.07 Jan, 2016, 10.13 PM IST
- Mylan launches hepatitis-C Sovaldi tablets in IndiaSovaldi is sold by Mylan's dedicated sales force as part of its Hepato Care segment.04 May, 2015, 02.51 PM IST
- Mylan Pharmaceuticals launches generic hepatitis C drug MyHep in IndiaUS-based company's Indian arm Mylan NV has launched generic Sofosbuvir tablets in strength of 400 mg under the name MyHep in the country, i...24 Apr, 2015, 03.45 PM IST
- Teva offers to buy Mylan for $40.1 billionTeva, the world’s biggest maker of generic medicines, offered $82 a share in cash and stock for Mylan, according to a statement.22 Apr, 2015, 04.42 AM IST
- Mylan-Abbott deal gets CCI green signalThe CCI observed that "there is horizontal overlap" between the pharmaceutical products of Mylan and Abbott in India with respect to certai...24 Nov, 2014, 07.23 PM IST
- Mylan launches breast cancer drug in IndiaDrug major Mylan Inc today said it has launched breast cancer drug Hertraz Herceptin in India.03 Feb, 2014, 08.41 PM IST
- Govt clears Mylan's Rs 5,168-cr deal to acquire Agila SpecialtiesThe decision was taken at a meeting of the Cabinet Committee of Economic Affairs held, Information and Broadcasting Minister Manish Tiwari ...03 Sep, 2013, 08.06 PM IST
- Lupin falls nearly 5% on Mylan drug launch, Credit Suisse downgradeCredit Suisse downgraded Lupin from ‘outperform’ to ‘neutral’ rating and upped the price target from Rs 710 earlier to Rs 755.20 May, 2013, 11.07 AM IST
- Settlement of Somaxon Pharmaceuticals patent suit in US soon: ZydusAhmedabad-based Zydus Cadila says, it agreed to settle a patent litigation suit with US-based Somaxon Pharmaceuticals for insomnia drug – S...20 Jul, 2012, 03.58 PM IST
- Dr Reddy's Laboratories, Mylan launch Clopidogrel tablets in US marketDr Reddy's Laboratories announced today that it has launched Clopidogrel tablets, USP, a bioequivalent generic version of Plavix in the US ...18 May, 2012, 06.20 PM IST
- Mylan Laboratories looks for partners to launch drugsMatrix Laboratories, which was acquired by Mylan , is exploring new partnerships in India to launch about 100 products.17 Aug, 2011, 06.02 PM IST
- Ranbaxy rebounds a day after Mylan sues FDA to block Lipitor copyMylan Pharma has sued the US FDA, seeking to terminate Ranbaxy's exclusive marketing rights to sell a lowcost version of Lipitor for six mo...22 Mar, 2011, 09.49 AM IST
- Mylan sues FDA to block Ranbaxy’s Lipitor copyMylan Pharmaceuticals has sued the US drug regulator, seeking to terminate Ranbaxy Laboratories’ exclusive marketing rights to sell a lowco...22 Mar, 2011, 05.22 AM IST
- Natco Pharma soars on drug licensing dealNatco Pharma rose as much as 19 per cent after it struck a licensing and supply deal with US-based Mylan for its generic version of multipl...11 Jun, 2008, 11.45 AM IST
- Matrix weighs Docpharma saleHyderabad-based Matrix Labs, in which US-based Mylan Labs holds a controlling stake, is toning up its business focus.29 Feb, 2008, 12.04 AM IST
Load More
